Acyl-CoA: cholesterol acyltransferases-2 gene polymorphism is associated with increased susceptibility to coronary artery disease in Uygur population in Xinjiang, China
Author(s) -
Yongtao Wang,
Buamina Maitusong,
Yi-Tong Ma,
Zhen-Yan Fu,
Yi-Ning Yang,
Xiang Ma,
XiaoMei Li,
Fen Liu,
BangDang Chen
Publication year - 2019
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20182129
Subject(s) - acyltransferases , coronary artery disease , polymorphism (computer science) , cholesterol , gene , genetics , gene polymorphism , population , biology , triglyceride , china , medicine , genotype , biosynthesis , environmental health , geography , archaeology
Acyl-CoA: cholesterol acyltransferases (ACAT) is the only enzyme that catalyzes the synthesis of cholesterol esters (CE) from free cholesterol and long-chain fatty acyl-CoA and plays a critical role in cellular cholesterol homeostasis. In the present study, our primary objective was to explore whether the single-nucleotide polymorphisms (SNPs) in ACAT-2 gene were associated with coronary artery disease (CAD) in Uygur subjects, in Xinjiang, China.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom